These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 9572539)

  • 1. A multicenter comparison of the ocular efficacy and safety of diclofenac 0.1% solution with that of ketorolac 0.5% solution in patients with acute seasonal allergic conjunctivitis.
    Tauber J; Raizman MB; Ostrov CS; Laibovitz RA; Abelson MB; Betts JG; Koester JM; Gill D; Schaich L
    J Ocul Pharmacol Ther; 1998 Apr; 14(2):137-45. PubMed ID: 9572539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-masked, paired-comparison clinical study of ketorolac tromethamine 0.5% ophthalmic solution compared with placebo eyedrops in the treatment of seasonal allergic conjunctivitis.
    Tinkelman DG; Rupp G; Kaufman H; Pugely J; Schultz N
    Surv Ophthalmol; 1993; 38 Suppl():133-40. PubMed ID: 8236004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of diclofenac sodium 0.1% ophthalmic solution in acute seasonal allergic conjunctivitis.
    Laibovitz RA; Koester J; Schaich L; Reaves TA
    J Ocul Pharmacol Ther; 1995; 11(3):361-8. PubMed ID: 8590268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evaluation of ketorolac tromethamine 0.5% ophthalmic solution for the treatment of seasonal allergic conjunctivitis.
    Ballas Z; Blumenthal M; Tinkelman DG; Kriz R; Rupp G
    Surv Ophthalmol; 1993; 38 Suppl():141-8. PubMed ID: 8236005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of ketorolac tromethamine, diclofenac sodium, and moist drops for ocular pain after radial keratotomy.
    McDonald MB; Brint SF; Caplan DI; Bourque LB; Shoaf K
    J Cataract Refract Surg; 1999 Aug; 25(8):1097-108. PubMed ID: 10445196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ketorolac for seasonal allergic conjunctivitis.
    Med Lett Drugs Ther; 1993 Sep; 35(905):88-9. PubMed ID: 8361452
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy and safety of ketorolac tromethamine 0.5% and levocabastine 0.05%: a multicenter comparison in patients with seasonal allergic conjunctivitis.
    Donshik PC; Pearlman D; Pinnas J; Raizman MB; Tauber J; Tinkelman D; Walters TR
    Adv Ther; 2000; 17(2):94-102. PubMed ID: 11010060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of the ocular efficacy and safety of diclofenac sodium (0.1%) ophthalmic solution with that of ketorolac tromethamine (0.5%) ophthalmic solution in patients with acute seasonal allergic conjunctivitis.
    Dehar N; Gupta A; Singh G
    Int J Appl Basic Med Res; 2012 Jan; 2(1):25-30. PubMed ID: 23776804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of a survey of patients with ocular allergy treated with topical ketorolac tromethamine.
    Raizman MB
    Clin Ther; 1995; 17(5):882-90. PubMed ID: 8595640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effects of ketorolac 0.5% or diclofenac 0.1% ophthalmic solutions on inflammation after cataract surgery.
    Flach AJ; Dolan BJ; Donahue ME; Faktorovich EG; Gonzalez GA
    Ophthalmology; 1998 Sep; 105(9):1775-9. PubMed ID: 9754191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical ketorolac 0.5% solution for the treatment of vernal keratoconjunctivitis.
    Sharma A; Gupta R; Ram J; Gupta A
    Indian J Ophthalmol; 1997 Sep; 45(3):177-80. PubMed ID: 9475021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized double-masked trial comparing ketorolac tromethamine 0.5%, diclofenac sodium 0.1%, and prednisolone acetate 1% in reducing post-phacoemulsification flare and cells.
    el-Harazi SM; Ruiz RS; Feldman RM; Villanueva G; Chuang AZ
    Ophthalmic Surg Lasers; 1998 Jul; 29(7):539-44. PubMed ID: 9674003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ketorolac tromethamine 0.5% ophthalmic solution in the treatment of moderate to severe ocular inflammation after cataract surgery: a randomized, vehicle-controlled clinical trial.
    Heier J; Cheetham JK; Degryse R; Dirks MS; Caldwell DR; Silverstone DE; Rosenthal A
    Am J Ophthalmol; 1999 Mar; 127(3):253-9. PubMed ID: 10088733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative evaluation of olopatadine ophthalmic solution (0.1%) versus ketorolac ophthalmic solution (0.5%) using the provocative antigen challenge model.
    Deschenes J; Discepola M; Abelson M
    Acta Ophthalmol Scand Suppl; 1999; (228):47-52. PubMed ID: 10337433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contact lens induced conjunctivitis: a model of human ocular inflammation.
    Friedlaender MH
    CLAO J; 1996 Jul; 22(3):205-8. PubMed ID: 8828938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the efficacy and safety of ketorolac tromethamine 0.5% and prednisolone acetate 1% after cataract surgery.
    Simone JN; Pendelton RA; Jenkins JE
    J Cataract Refract Surg; 1999 May; 25(5):699-704. PubMed ID: 10330648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time to onset and duration of action of the antihistamine bepotastine besilate ophthalmic solutions 1.0% and 1.5% in allergic conjunctivitis: a phase III, single-center, prospective, randomized, double-masked, placebo-controlled, conjunctival allergen challenge assessment in adults and children.
    Abelson MB; Torkildsen GL; Williams JI; Gow JA; Gomes PJ; McNamara TR;
    Clin Ther; 2009 Sep; 31(9):1908-21. PubMed ID: 19843481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of 0.1% olopatadine hydrochloride and 0.5% ketorolac tromethamine in the treatment of seasonal allergic conjunctivitis.
    Yaylali V; Demirlenk I; Tatlipinar S; Ozbay D; Esme A; Yildirim C; Ozden S
    Acta Ophthalmol Scand; 2003 Aug; 81(4):378-82. PubMed ID: 12859265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the analgesic efficacy and safety of nepafenac ophthalmic suspension compared with diclofenac ophthalmic solution for ocular pain and photophobia after excimer laser surgery: a phase II, randomized, double-masked trial.
    Colin J; Paquette B
    Clin Ther; 2006 Apr; 28(4):527-36. PubMed ID: 16750464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety profile of ketorolac 0.5% ophthalmic solution in the prevention of surgically induced miosis during cataract surgery.
    Stewart R; Grosserode R; Cheetham JK; Rosenthal A
    Clin Ther; 1999 Apr; 21(4):723-32. PubMed ID: 10363737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.